ID   Chromphi-2
AC   CVCL_X545
SY   chromphi-2
DR   Wikidata; Q54813290
RX   CelloPub=CLPUB00407;
RX   CelloPub=CLPUB00411;
RX   PubMed=8932342;
RX   PubMed=11139287;
CC   Doubling time: 40 hours (PubMed=8932342).
CC   Misspelling: chromhpi-2; Note=In Cellosaurus releases 10 to 23.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C6975; Papillary renal cell carcinoma
DI   ORDO; Orphanet_319298; Papillary renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 8
//
RX   CelloPub=CLPUB00407;
RA   Krieg A.;
RT   "Characterization and functional analysis of the TRAIL system and
RT   the inhibitor of apoptosis protein (IAP) family in human neoplasia.";
RL   Thesis MD (2005); Heinrich-Heine-Universitat Dusseldorf; Dusseldorf; Germany.
//
RX   CelloPub=CLPUB00411;
RA   Petek O.;
RT   "Analysis of expression and mutation of the antimetastatic gene NM23 in
RT   human renal carcinoma cell lines and epithelioid sarcomas.";
RL   Thesis MD (2002); Heinrich-Heine-Universitat Dusseldorf; Dusseldorf; Germany.
//
RX   PubMed=8932342; DOI=10.1038/bjc.1996.596; PMCID=PMC2074836;
RA   Gerharz C.-D., Hildebrandt B., Moll R., Ramp U., Sarbia M., Storkel S.,
RA   Koldovsky P., Gabbert H.E.;
RT   "Chromophilic renal cell carcinoma: cytomorphological and cytogenetic
RT   characterisation of four permanent cell lines.";
RL   Br. J. Cancer 74:1605-1614(1996).
//
RX   PubMed=11139287; DOI=10.1038/sj.cdd.4400746;
RA   Dejosez M., Ramp U., Mahotka C., Krieg A., Walczak H., Gabbert H.E.,
RA   Gerharz C.-D.;
RT   "Sensitivity to TRAIL/APO-2L-mediated apoptosis in human renal cell
RT   carcinomas and its enhancement by topotecan.";
RL   Cell Death Differ. 7:1127-1136(2000).
//